Adaptateurs de Signalisation en Hématologie
- Research works
- 2 ▼ 100% vs 2013–17
- Citations
- 40 19.9 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 80% world 28%
Not ranked overall: Adaptateurs de Signalisation en Hématologie is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which research topics does Adaptateurs de Signalisation en Hématologie publish most on?
By volume in 2022–2025: Mitochondrial Function and Pathology, Genetic Neurodegenerative Diseases and Parkinson's Disease Mechanisms and Treatments.
- 1 Mitochondrial Function and Pathology Molecular Biology 0 works
- 2 Genetic Neurodegenerative Diseases Cellular and Molecular Neuroscience 0 works
- 3 Parkinson's Disease Mechanisms and Treatments Neurology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Adaptateurs de Signalisation en Hématologie's research output changed?
Output in 2018–2022 was 100% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Bobigny
- Hôpital Avicenne
- Association pour la Recherche en Physiologie de l’Environnement
- Equipe de Recherche en Epidémiologie Nutritionnelle
- Hypoxie et Poumon
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.